Summary
This prediction is currently active. The prediction for Altimmune disappoints with a performance of -26.28%. This prediction currently runs until 18.03.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Altimmune | -9.259% | -9.259% |
| iShares Core DAX® | 0.300% | 4.701% |
| iShares Nasdaq 100 | 0.434% | 12.255% |
| iShares Nikkei 225® | 1.633% | 12.616% |
| iShares S&P 500 | 0.566% | 7.786% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Altimmune diskutieren
Altimmune (ALT) is now covered by Truist Financial Corporation. They set a "buy" rating and a $12.00 price target on the stock.
Ratings data for ALT provided by MarketBeat